Amy Nguyen Jan 27 Inexplicable Vyvanse Leak: Unraveling The Mystery - OpenSIPS Trunking Solutions Overview Nov 1, 2024 · soon after vyvanse’s patent expired in 2023, applications for generic formulations of lisdexamfetamine dimesylate started flowing into the fda. There are now 18 approved.